Physician profile
Robert B Weinstein
NPI 1346244886
$393,695.44
in general payments reported to CMS, 2019-2025
30 companies · $33K in 2025
The $33K reported for 2025 was more than what 98% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $51K · 2021: $50K · 2022: $78K · 2023: $66K · 2024: $53K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $149K · Food and Beverage: $1,932 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $149,143.23 |
| Food and Beverage | $1,932.23 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $279,955.42 | 2019-2025 | 12mm Htr Implant System, Non-Sterile |
| Fuse Medical, INC. | $97,778.72 | 2020-2025 | Orbitum Staple System |
| Encore Medical, Lp | $9,699.64 | 2021 | |
| Cpm Medical Consultants, LLC | $2,836.59 | 2020-2024 | Orbitum Staple System |
| Biopro, INC. | $1,274.67 | 2025 | Hemi Toe |
| Alafair Biosciences, INC. | $345.06 | 2025 | Versawrap |
| Horizon Therapeutics Plc | $268.17 | 2020-2023 | Krystexxa |
| Depuy Synthes Sales INC. | $203.96 | 2023-2025 | Na, Fibergraft Aeridyan Matrix, Crosstie |
| Bioventus LLC | $194.69 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Dynasplint Systems INC. | $163.78 | 2025 | Dynasplint |
| Organogenesis INC. | $141.02 | 2025 | Via Matrix |
| Medtronic, INC. | $133.33 | 2024 | Closurefast |
| Linvatec Corporation | $120.91 | 2023 | 5ms |
| Paragon 28, INC. | $114.78 | 2023-2024 | Apex 3d, Monkey Rings |
| Arteriocyte Medical Systems, INC. | $78.21 | 2025 | Magellan |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuros Medical, INC. | $73.08 | 2025 | Altius |
| Medtronic Vascular, INC. | $52.05 | 2019 | |
| Paratek Pharmaceuticals, INC. | $47.90 | 2021-2022 | |
| Treace Medical Concepts, INC. | $33.11 | 2022-2025 | |
| Nevro Corp. | $21.80 | 2021 | |
| Arthrosurface Incorporated | $19.80 | 2019 | |
| Zyla Life Sciences, INC. | $18.34 | 2019 | |
| Maruho Medical, INC. | $17.86 | 2020 | |
| Zimmer Biomet Holdings, INC. | $17.49 | 2020 | |
| Alfasigma USA, INC. | $17.47 | 2021 | |
| Axogen | $15.61 | 2019 | |
| Smith+Nephew, INC. | $14.41 | 2023 | Bone Anchors With Arthroscopic Delivery System |
| Nabriva Therapeutics, Plc | $13.25 | 2022 | |
| Reprise Biomedical, INC. | $12.28 | 2022 | |
| Stryker Corporation | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Weinstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.